Literature DB >> 5858571

Clinical trials with 1,3-bis(2-chloroethyl)-1-nitrosourea, NSC-409962.

V T De Vita, P P Carbone, A H Owens, G L Gold, M J Krant, J Edmonson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5858571

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  28 in total

1.  Treatment of recurrent malignant glioma with BCNU-fluosol and oxygen inhalation. A phase I-II study.

Authors:  F Hochberg; M Prados; C Russell; D Weissman; R Evans; P Cook; G Burton; P D Eisenberg; R Valenzuela; L Verkh
Journal:  J Neurooncol       Date:  1997-03       Impact factor: 4.130

Review 2.  Chemotherapy-associated renal dysfunction.

Authors:  Vaibhav Sahni; Devasmita Choudhury; Ziauddin Ahmed
Journal:  Nat Rev Nephrol       Date:  2009-06-30       Impact factor: 28.314

3.  In vitro evaluation of a new nitrosourea, TCNU, against human small cell lung cancer cell lines.

Authors:  H Roed; L L Vindeløv; M Spang-Thomsen; I J Christensen; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

4.  Disappearance of disseminated pancreatic carcinoma with combined chemotherapy.

Authors:  J J Lokich; J R Brooks
Journal:  Ann Surg       Date:  1973-01       Impact factor: 12.969

Review 5.  An assessment of massive-dose chemotherapy of malignant disease.

Authors:  D E Bergsagel
Journal:  Can Med Assoc J       Date:  1971-01-09       Impact factor: 8.262

Review 6.  Treatments for astrocytic tumors in children: current and emerging strategies.

Authors:  Stanislaw R Burzynski
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 7.  Intestinal and liver toxicity of antineoplastic drugs.

Authors:  G B McDonald; N Tirumali
Journal:  West J Med       Date:  1984-02

8.  A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumors.

Authors:  L G Feun; D J Stewart; M E Leavens; M A Burgess; N Savaraj; R S Benjamin; G P Bodey
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

9.  Antitumor activity of a nitrosourea derivative, CNUA, on murine tumors.

Authors:  K Edanami; K Komiyama; T Kuroda; I Umezawa
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

10.  Improved delivery through biological membranes. XLV. Synthesis, physical-chemical evaluation, and brain uptake studies of 2-chloroethyl nitrosourea delivery systems.

Authors:  K Raghavan; T Loftsson; M E Brewster; N Bodor
Journal:  Pharm Res       Date:  1992-06       Impact factor: 4.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.